Gritstone Bio Shares Outstanding 2017-2021 | GRTS

Gritstone Bio shares outstanding from 2017 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Gritstone Bio Annual Shares Outstanding
(Millions of Shares)
2020 38
2019 34
2018 9
2017 2
2016 2
Gritstone Bio Quarterly Shares Outstanding
(Millions of Shares)
2021-09-30 78
2021-06-30 77
2021-03-31 77
2020-12-31 38
2020-09-30 38
2020-06-30 37
2020-03-31 37
2019-12-31 34
2019-09-30 36
2019-06-30 34
2019-03-31 29
2018-12-31 9
2018-09-30 2
2018-06-30 2
2018-03-31 2
2017-12-31
2017-09-30 2
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.425B $0.004B
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69